igf-1 lr3 human trial IGF-1LR3 IGF-1 LR3 - 1mg -
Description
Administration of MTX (5 mg/kg) to day 4 produced a significant decrease in hepatic glutathione (GSH) levels and a significant increase in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) liver enzymes, hepatic malondialdehyde (MDA), tumor suppressor protein (p53), Il-6 and IL-1 levels compared to the control group
Gao G, You L, Zhang J, Chang Y, Yu P
[PubMed] 26
So what is half-life, really
